Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

G. G. Hanna*, T. Illidge

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer.

Original languageEnglish
Pages (from-to)726-731
Number of pages6
JournalClinical Oncology
Volume28
Issue number11
Early online date9 Aug 2016
DOIs
Publication statusPublished - 1 Nov 2016

Keywords

  • Checkpoint inhibition
  • immunotherapy
  • NSCLC
  • radiotherapy

Fingerprint

Dive into the research topics of 'Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?'. Together they form a unique fingerprint.

Cite this